INSP Inspire Medical Systems, Inc.

NYSE inspiresleep.com


$ 78.83 $ 1.16 (1.49 %)    

Tuesday, 14-Oct-2025 15:59:57 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 78.84
$ 76.82
$ 76.00 x 5
$ 80.29 x 10
-- - --
$ 70.77 - $ 216.01
593,625
na
2.33B
$ 1.26
$ 43.89
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-05-2025 03-31-2025 10-Q
3 02-10-2025 12-31-2024 10-K
4 11-04-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-09-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-10-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-15-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-02-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 06-07-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 inspire-medical-publishes-inspire-v-clinical-outcomes-data-from-singapore-clinical-study-and-limited-market-release-in-us-including-single-site-experience-at-two-leading-centers-data-to-be-presented-at-aao-hns-and-isss-meetings

Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...

 evercore-isi-group-maintains-outperform-on-inspire-medical-systems-lowers-price-target-to-125

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the p...

 kenneth-griffin-reports-58-passive-stake-in-inspire-medical-systems-as-of-sept-29

https://www.sec.gov/Archives/edgar/data/1609550/000110465925097180/xslSCHEDULE_13G_X01/primary_doc.xml

 ubs-downgrades-inspire-medical-systems-to-neutral-lowers-price-target-to-89

UBS analyst Danielle Antalffy downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Neutral and lowers the price target...

Core News & Articles

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025,...

 evercore-isi-group-initiates-coverage-on-inspire-medical-systems-with-outperform-rating-announces-price-target-of-150

Evercore ISI Group analyst Daniel Markowitz initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Outperform rati...

 inspire-medical-systems-affirms-fy2025-gaap-eps-guidance-of-040-050-vs-227-est-affirms-fy2025-sales-guidance-of-900000m-910000m-vs-949364m-est

Inspire Medical Systems (NYSE:INSP) affirms FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.40-$0.50 vs $2.27 analyst estimate....

 inspire-medical-cfo-rick-buchholz-to-step-down-by-year-end-will-stay-in-advisory-role-through-february-2026

Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...

 leerink-partners-maintains-market-perform-on-inspire-medical-systems-lowers-price-target-to-97

Leerink Partners analyst Mike Kratky maintains Inspire Medical Systems (NYSE:INSP) with a Market Perform and lowers the pric...

 inspire-medical-stock-strays-off-course-amid-structural-setback

Inspire Medical's chart structure signals weakness after a major breakdown. Here's why investors may want to avoid the ...

 stock-market-today-us-futures-edge-higher-as-investors-await-earnings-from-mcdonalds-uber-and-walt-disney

US stock futures rose on Wed. after falling on Thurs. Trump threatened tariffs on imported pharma up to 250%. Bond yields down ...

 inspire-medical-plunges-on-outlook-cut-weak-v-system-rollout-analysts-react

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved I...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION